4.8 Article

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A-RNA Complex

Heather Sadlish et al.

ACS CHEMICAL BIOLOGY (2013)

Review Biochemistry & Molecular Biology

Tumor adaptation and resistance to RAF inhibitors

Piro Lito et al.

NATURE MEDICINE (2013)

Review Pharmacology & Pharmacy

Challenging resistance mechanisms to therapies for metastatic melanoma

Lucio Tentori et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2013)

Article Biochemistry & Molecular Biology

BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma

Y. Shao et al.

CELL DEATH AND DIFFERENTIATION (2012)

Article Chemistry, Medicinal

Synthetic Silvestrol Analogues as Potent and Selective Protein Synthesis Inhibitors

Tao Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

A unifying model for mTORC1-mediated regulation of mRNA translation

Carson C. Thoreen et al.

NATURE (2012)

Review Oncology

The biological and therapeutic relevance of mRNA translation in cancer

Sarah P. Blagden et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Review Oncology

Translational control in cancer

Deborah Silvera et al.

NATURE REVIEWS CANCER (2010)

Article Oncology

Identification of direct transcriptional targets of V600EBRAF/MEK signalling in melanoma

Leisl M. Packer et al.

PIGMENT CELL & MELANOMA RESEARCH (2009)

Article Multidisciplinary Sciences

V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway

Christine A. Pratilas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)